SANGAMO THERAPEUTICS, INC. Impairment of Leasehold
SANGAMO THERAPEUTICS, INC. (SGMOQ) reported Impairment of Leasehold of $200.00 thousand for the 9-month period ending 2024-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfLeasehold · last filed 2026-03-30
- SANGAMO THERAPEUTICS, INC. impairment of leasehold for the quarter ending 2024-09-30 was $0.00.
- SANGAMO THERAPEUTICS, INC. impairment of leasehold for the quarter ending 2024-06-30 was $200.00K.
- SANGAMO THERAPEUTICS, INC. impairment of leasehold for the quarter ending 2024-03-31 was $500.00K, a 90.00% decline year-over-year.
- SANGAMO THERAPEUTICS, INC. impairment of leasehold for the quarter ending 2023-03-31 was $5.00M.
- SANGAMO THERAPEUTICS, INC. impairment of leasehold for fiscal 2023 was $18.70M.
| Period end | Impairment of Leasehold 3 month | Impairment of Leasehold 3 month as first filed | Impairment of Leasehold 6 month | Impairment of Leasehold 9 month | Impairment of Leasehold 12 month |
|---|---|---|---|---|---|
| 2024-12-31 | $200.00K 10-K · filed 2026-03-30 | ||||
| 2024-09-30 | $0.00 10-Q · filed 2025-11-06 | $200.00K derived: sum of 2 quarters · filed 2025-11-06 | $700.00K 10-Q · filed 2025-11-06 | ||
| 2024-06-30 | $200.00K 10-Q · filed 2025-08-07 | $100.00K 10-Q · filed 2024-08-06 | $700.00K 10-Q · filed 2025-08-07 | ||
| 2024-03-31 | $500.00K 10-K · filed 2026-03-30 | ||||
| 2023-12-31 | $18.70M 10-K · filed 2025-03-17 | ||||
| 2023-03-31 | $5.00M 10-Q · filed 2024-11-12 |